|
Symbol
|
Z0AH5Z | Z0ARGZ | Z0B2CZ | RMA18V | Z0B4DZ | Z0B9OZ | Z0BJ2Z | Z0BJ1Z | Z0BLGZ | 1175BC | 1176BC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Sous-jacent
|
Bristol-Myers Squibb Co. / Johnson & Johnson / Merck & Co. Inc. / Pfizer Inc. | Bristol Myers / Eli Lilly / Pfizer | Bristol-Myers Squibb Co. / Johnson & Johnson / Merck & Co. Inc. | Bristol-Myers Squibb Co. / Johnson & Johnson / Pfizer Inc. / UnitedHealth Group Inc. | Bristol Myers / Eli Lilly / Pfizer | Bristol-Myers Squibb / Eli Lilly / Pfizer / Johnson & Johnson | Bristol-Myers Squibb Co. / SAP SE / Vinci S.A. | Bristol-Myers Squibb Co. / SAP SE / Vinci S.A. | Bristol-Myers Squibb Co. / Partners Group Hldg. AG / Walt Disney Co. | Bristol Myers / Merck & Co. / Pfizer | Bristol Myers / Merck & Co. / Pfizer |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
24.06.2026 | 03.09.2026 | 12.05.2026 | 09.11.2026 | 27.05.2026 | 07.07.2026 | 08.03.2027 | 08.03.2027 | 15.03.2027 | 21.01.2027 | 21.01.2027 |
| Demande | - | - | - | 101,60 | - | - | - | - | - | 96,81 | 97,22 |
| Offre | - | - | - | 102,60 | - | - | - | - | - | 97,58 | 97,99 |